These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 12194224)

  • 1. [Active immunization against tick-born encephalitis (TBE) among border guards (1993-2002)].
    Knap J; Ryba S
    Przegl Epidemiol; 2002; 56 Suppl 1():110-6. PubMed ID: 12194224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study.
    Jílková E; Vejvalková P; Stiborová I; Skorkovský J; Král V
    Expert Opin Biol Ther; 2009 Jul; 9(7):797-803. PubMed ID: 19527104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules.
    Wittermann C; Schöndorf I; Gniel D
    Vaccine; 2009 Mar; 27(10):1661-6. PubMed ID: 18940221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination against tick-borne encephalitis--distant evaluation.
    Bobrowska E; Grzeszczuk A; Prokopowicz D
    Rocz Akad Med Bialymst; 1996; 41(1):44-50. PubMed ID: 8673804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunity against tick borne encephalitis virus (TBE) in population of forest workers in Bialowieza].
    Siennicka J; Trzcińska A; Gut W
    Przegl Epidemiol; 2010; 64(2):303-5. PubMed ID: 20731242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of serum levels of tick-borne encephalitis (TBE) virus antibodies after administration of FSME inject vaccine].
    Pancewicz SA; Hermanowska-Szpakowicz T
    Przegl Epidemiol; 2002; 56 Suppl 1():116-21. PubMed ID: 12194225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TBE infection in an incomplete immunized person at-risk who lives in a high-endemic area--impact on current recommendations for immunization of high-risk groups.
    Plísek S; Honegr K; Beran J
    Vaccine; 2008 Jan; 26(3):301-4. PubMed ID: 18082914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Field effectiveness of vaccination against tick-borne encephalitis.
    Heinz FX; Holzmann H; Essl A; Kundi M
    Vaccine; 2007 Oct; 25(43):7559-67. PubMed ID: 17869389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.
    Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Firth C; Petermann R; Barrett PN; Ehrlich HJ
    Vaccine; 2011 Oct; 29(43):7307-19. PubMed ID: 21843576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamics of antibody formation after vaccination against tick-borne encephalitis].
    Pazdiora P; Januska J
    Epidemiol Mikrobiol Imunol; 2004 Feb; 53(1):17-21. PubMed ID: 15052830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
    Wittermann C; Petri E; Zent O
    Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.
    Loew-Baselli A; Konior R; Pavlova BG; Fritsch S; Poellabauer E; Maritsch F; Harmacek P; Krammer M; Barrett PN; Ehrlich HJ;
    Vaccine; 2006 Jun; 24(24):5256-63. PubMed ID: 16624457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.
    Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB
    Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in vaccination against tick-borne encephalitis.
    Rendi-Wagner P
    Expert Rev Vaccines; 2008 Jul; 7(5):589-96. PubMed ID: 18564014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of immunogenicity and safety between two paediatric TBE vaccines.
    Pöllabauer EM; Pavlova BG; Löw-Baselli A; Fritsch S; Prymula R; Angermayr R; Draxler W; Firth C; Bosman J; Valenta B; Harmacek P; Maritsch F; Barrett PN; Ehrlich HJ
    Vaccine; 2010 Jun; 28(29):4680-5. PubMed ID: 20433803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior.
    Prymula R; Pöllabauer EM; Pavlova BG; Löw-Baselli A; Fritsch S; Angermayr R; Geisberger A; Barrett PN; Ehrlich HJ
    Hum Vaccin Immunother; 2012 Jun; 8(6):736-42. PubMed ID: 22699436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological response in HIV-positive patients vaccinated against tick-borne encephalitis.
    Panasiuk B; Prokopowicz D; Panasiuk A
    Infection; 2003 Jan; 31(1):45-6. PubMed ID: 12590332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination against tick-borne encephalitis in the Central Slovakia Region using a Soviet vaccine].
    Palanová A; Gresíková M; Sekeyová M; Pötheová A; Galvánek I; Januska J
    Cesk Epidemiol Mikrobiol Imunol; 1992 Jun; 41(2):69-77. PubMed ID: 1387048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. After a tick bite in a tick-borne encephalitis virus endemic area: current positions about post-exposure treatment.
    Bröker M; Kollaritsch H
    Vaccine; 2008 Feb; 26(7):863-8. PubMed ID: 18206274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Active vaccination against early summer meningoencephalitis].
    Müller A
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1110-6. PubMed ID: 9691346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.